Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company. It develops off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company was founded on February 14, 2024 and is headquartered in Warren, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Tevogen Bio Holdings Inc. - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Tevogen Bio Holdings Inc. - Ordinary Shares - Class A market cap is $71.33M.
What is the 52-week high for Tevogen Bio Holdings Inc. - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Tevogen Bio Holdings Inc. - Ordinary Shares - Class A 52 week high is $12.03 as of October 21, 2025.
What is the 52-week low for Tevogen Bio Holdings Inc. - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Tevogen Bio Holdings Inc. - Ordinary Shares - Class A 52 week low is $4.08 as of October 21, 2025.
What is Tevogen Bio Holdings Inc. - Ordinary Shares - Class A stock price today?
Tevogen Bio Holdings Inc. - Ordinary Shares - Class A stock price today is $4.51.
What was Tevogen Bio Holdings Inc. - Ordinary Shares - Class A stock price yesterday?
Tevogen Bio Holdings Inc. - Ordinary Shares - Class A stock price yesterday was $4.51.
What is the PE ratio of Tevogen Bio Holdings Inc. - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Tevogen Bio Holdings Inc. - Ordinary Shares - Class A’s P/E ratio is 65.55.
What is the Price-to-Book ratio of Tevogen Bio Holdings Inc. - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Tevogen Bio Holdings Inc. - Ordinary Shares - Class A P/B ratio is 7.2440.
What is Tevogen Bio Holdings Inc. - Ordinary Shares - Class A's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Tevogen Bio Holdings Inc. - Ordinary Shares - Class A's EBITDA is -93.63.
What is the 50-day moving average of Tevogen Bio Holdings Inc. - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Tevogen Bio Holdings Inc. - Ordinary Shares - Class A 50-day moving average is $9.43.
